Takeover shows interest in Chinese biotech companies
Yet another international biotech group acquires a successful Chinese company. Genmab AS from Copenhagen buys ProfoundBio, which has developed new cancer therapies, for 1.8 billion US dollars.
By Christiane Kuehl